International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (Q34116505)

31 July 2017

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (English)

1 reference

31 July 2017

1 reference

1 reference

Daphna Birenbaum-Carmeli

2

Daphna Birenbaum-Carmeli

1 reference

31 July 2017

Siranoush Manoukian

17

0 references

William David Foulkes

William D Foulkes

8

0 references

Susan M Domchek

14

Susan Domchek

1 reference

31 July 2017

3

Jan Lubinski

1 reference

31 July 2017

18

Fergus Couch

1 reference

31 July 2017

20

Steven A Narod

1 reference

31 July 2017

4

Jacek Gronwald

1 reference

31 July 2017

7

Parviz Ghadirian

1 reference

31 July 2017

11

Charmaine Kim-Sing

1 reference

Hereditary Breast Cancer Clinical Study Group

31 July 2017

21

Hereditary Breast Cancer Clinical Study Group

1 reference

31 July 2017

16

Nadine Tung

1 reference

31 July 2017

12

Peter Ainsworth

1 reference

31 July 2017

6

Pal Moller

1 reference

31 July 2017

1

Kelly A Metcalfe

1 reference

31 July 2017

9

Jan Klijn

1 reference

31 July 2017

15

Teresa Wagner

1 reference

31 July 2017

Henry Lynch

5

1 reference

31 July 2017

Eitan Friedman

10

1 reference

31 July 2017

Barry Rosen

13

1 reference

31 July 2017

Ping Sun

19

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

International Journal of Cancer

31 July 2017

1 reference

31 July 2017

122

1 reference

31 July 2017

2017-2022

1 reference

31 July 2017

9

1 reference

Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

A descriptive study of BRCA1 testing and reactions to disclosure of test results

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936778

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

28 October 2018

1 reference

12 December 2020

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

1 reference

12 December 2020

The practice of prophylactic mastectomy: a survey of Maryland surgeons

1 reference

12 December 2020

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

1 reference

12 December 2020

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

12 December 2020

Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines

1 reference

12 December 2020

Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy

1 reference

12 December 2020

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.23340

1 reference

31 July 2017

1 reference

31 July 2017

1 reference